Follow the 司太立 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 司太立 has logged 6 insider filings. Market capitalisation: €4.5bn. The latest transaction was filed on 29 June 2026 (Sale). Among the most active insiders: 胡锦生. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
司太立 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It specializes in the development and production of medicines and pharmaceutical products.